NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inspire Medical Systems, Inc. ("Inspire" or "the Company") (NYSE:INSP). Investors who purchased Inspire securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/INSP.
Investigation Details
On August 4, 2025, Inspire reported Q2 earnings, lowering its full-year revenue guidance and disclosing delays in the rollout of its "Inspire V" system. The Company revealed that treatment centers had postponed the adoption of its new system due to not being able to bill Medicare until July 1, 2025. Following this news, Inspire stock dropped almost 40.6% in intraday trading on August 5, 2025.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Inspire securities, you can assist this investigation by visiting the firm’s site: bgandg.com/INSP. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
COMTEX_467837276/2457/2025-08-06T13:04:04